Evaluating anti-thymocyte globulin induction doses for better allograft and patient survival in Asian kidney transplant recipients.

MLA

Shim, Ye Eun, et al. “Evaluating Anti-Thymocyte Globulin Induction Doses for Better Allograft and Patient Survival in Asian Kidney Transplant Recipients.” Scientific Reports, vol. 13, no. 1, Aug. 2023, p. 12560. EBSCOhost, https://doi.org/10.1038/s41598-023-39353-6.

APA

Shim, Y. E., Ko, Y., Lee, J. P., Jeon, J. S., Jun, H., Yang, J., Kim, M. S., Lim, S. J., Kwon, H. E., Jung, J. H., Kwon, H., Kim, Y. H., Lee, J., & Shin, S. (2023). Evaluating anti-thymocyte globulin induction doses for better allograft and patient survival in Asian kidney transplant recipients. Scientific Reports, 13(1), 12560. https://doi.org/10.1038/s41598-023-39353-6

Chicago

Shim, Ye Eun, Youngmin Ko, Jung Pyo Lee, Jin Seok Jeon, Heungman Jun, Jaeseok Yang, Myoung Soo Kim, et al. 2023. “Evaluating Anti-Thymocyte Globulin Induction Doses for Better Allograft and Patient Survival in Asian Kidney Transplant Recipients.” Scientific Reports 13 (1): 12560. doi:10.1038/s41598-023-39353-6.